Table 1 Characteristics of the eligible studies
From: A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia
Author | Location | Ys | n | Number of resistant isolates (%) | |||||
|---|---|---|---|---|---|---|---|---|---|
Amp | Sxt | Chl | Cro | Cip | MDR | ||||
[12] | AA | 1974-1981 | 216 | nr | 0(0) | nr | nt | nt | 39(18.1) |
[32] | AA | 1975-1980 | 165 | 22(13.3) | 0(0) | 19(11.5) | nt | nt | 23(13.9) |
[33]a | AA | 1982-1983 | 45 | 12(26.7) | 0(0) | 8(17.8) | nt | nt | 10(22.2) |
[34]b | AA | 1992-1993 | 37 | 30(81.1) | 28(75.7) | 31(83.8) | nt | nt | 30(81.1) |
[35] | AA | 1993-1996 | 110 | 40(36.4) | 57(51.8) | 39(35.5) | nt | nt | 41(37.3) |
[36]b | AA | 1995 | 45 | 31(68.9) | 26(57.8) | 21(46.7) | nt | nt | 26(57.8) |
[37] | JM | 2000 | 59 | 35(59.3) | 24(40.7) | 21(35.6) | nt | nt | 45(76.3) |
[38]b | GD | 2003-2005 | 59 | 54(91.5) | 38(64.4) | 46(78.0) | nt | 6(10.2) | 46(78) |
[13]b | AA/JM | 2004-2006 | 113 | 93(82.3) | 91(80.5) | 92(81.4) | 89(78.8) | 1(0.9) | 91(80.5) |
[39] | BD | 2003-2008 | 84 | 77(91.7) | 67(79.8) | 37(44.1) | nt | nt | 72(85.7) |
[40]c | HR | 2007 | 28 | 28(100) | nt | 18(64.3) | nt | nt | 20(71.4) |
[41]d,e | DM | 2007-2009 | 8 | 8(100) | 8(100) | 8(100) | 8 (100) | 0(0) | 8(100) |
[14]d,e, | EU/USA | 2003-2007 | 35 | 34(97.1) | 35(100) | 35(100) | 34(97.1) | 0(0) | 35(100) |
[15]d,e | BL | 2006-2009 | 26 | 26 (100) | 26(100) | 26(100) | 26(100) | 0(0) | 26(100) |